When Antidepressants FAILED?! Psychiatry Residency and Psychiatry Board Review

Описание: Psychiatry residency gets much harder when first-line antidepressants fail. In this video, we cover treatment-resistant depression (TRD), antidepressant augmentation strategies, lithium for suicidality, ketamine/esketamine, newer antidepressants, postpartum depression treatments, and how attendings actually think through difficult depression cases in real clinical practice.

Topics covered include:
Treatment-resistant depression (TRD)
Lithium augmentation for suicidal ideation
Esketamine (Spravato)
Auvelity
Vortioxetine (Trintellix)
Vilazodone (Viibryd)
Lumateperone (Caplyta)
Mirtazapine
Bupropion (Wellbutrin)
MAOIs
Postpartum depression
Brexanolone (Zulresso)
Zuranolone (Zurzuvae)
Antidepressant augmentation
Aripiprazole augmentation
Psychiatry resident education
Psychopharmacology
Major depressive disorder (MDD)
Treatment algorithms for depression

This video is designed for:

Psychiatry residents
Medical students
Psych NPs/PAs
Practicing clinicians
Anyone studying psychopharmacology or preparing for PRITE/psychiatry boards

#psychiatry #psychiatryresident #psychopharmacology #antidepressants #treatmentresistantdepression #ketamine #lithium #majordepressivedisorder #spravato #psycheducation #prite #psychiatryboards #mentalhealtheducation #postpartumdepression